Overview

Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the MTD of the combination of everolimus plus axitinib in solid tumors, especially RCC.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital, Bordeaux
Treatments:
Axitinib
Everolimus
Sirolimus